Some Things that You Should Know Regarding Bipolar Depression
You must understand that bipolar disorder is a kind of condition which affects all types of individuals. The children and adults are being affected by such condition. This is a fact that you should know. Women would suffer the most from this kind of depression that is called bipolar depression disorder.
It is not strange in any case since even if women suffer from such regular bipolar kind of depression or a depressive disorder, they would spend more time depressed than they do being manic. This isn’t to say that only the women are depressive, the men also are and they may get affected by such condition.
The bipolar kind of disorder is also known as manic depression since such is a mental condition wherein you interchange often between such phases of depression and mania. If you are suffering from bipolar depression, you won’t be spending as much time being manic as you would spend being depressed.
This type of depression is one form of disorder and you should understand that it is really easy to wrongly diagnose as bipolar disorder due to the similarity in their symptoms. Because of this, the doctor must have to keep you around for a long time when they would try to diagnose the condition that you have. It is surely not flattering to either of you when you get treated for a wrong thing.
Such bipolar affective disorder is another name for the bipolar disorder or such manic-depressive illness. However, you don’t want to mistake such for bipolar depression disorder. Such is closely related with all of the symptoms of such depressive phase of the bipolar disorder, but very few of the mania.
Monotherapy trials against the placebo is the gold-standard design when determining the efficacy in treating bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without such established need for the long-term medication can be suitable for those clinical trials that require placebo-controls. Such switch to mania or the hypomania can perhaps be the result of the active treatment for such bipolar depression.
Some medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch unlike the others but such increased rate of the switch can’t be seen until around ten weeks of treatment. Hence, the 12-week trials against placebo are required to determine such risk of switch and to establish such continuing effects. Know that such careful assessments at six to eight weeks are needed to ensure that the patients who fail to respond don’t continue in the study for such unacceptable periods of time.